Group A, C Meningococcal Polysaccharide-Conjugate Vaccine
Product Description
Chongqing Zhifei Biological Products Co., Ltd.
-
CN
-
2015On CPHI since
-
5000+Employees
Company types
Categories
Specifications
Chongqing Zhifei Biological Products Co., Ltd.
-
CN
-
2015On CPHI since
-
5000+Employees
Company types
More Products from Chongqing Zhifei Biological Products Co., Ltd. (4)
-
Product Recombinant COVID-19 Vaccine(CHO Cell)
Zifivax is the first approved Recombinant COVID vaccine, there are more than 300million doses used worldwide. -
Product Recombinant Mycobacterium Tuberculosis Fusion Protein
C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1)Suitable for Large Scale LTBI Screening;
(2)Non Cross-React with BCG Vaccine;
(3)WHO Guideline Recommended; q... -
Product semaglutide
we can supply the semaglutide API with a good price and good quality,we are also open for the cooperation model. -
Product Meningococcal Polysaccharide Vaccine
Chongqing zhifei biological products co., ltd offers a wide range of products which includes meningococcal polysaccharide vaccine. Function and use: it can be used to prevent epidemic cerebrospinal meningitis caused by meningococcus group a, c, y, and w135 infection. Contact us for more information.
Chongqing Zhifei Biological Products Co., Ltd. resources (1)
-
Brochure Zhifei Profile
Zhifei Profile
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance